Shareholder Structure

58.7% Free float

• 4.9% Paladin Asset Management*
• 4.7% SEB Investment Management AB

19.7% Martin Hesse
Incl. attribution of BMSH GmbH

14.9% Luxempart Invest S.á.r.l.

6.7% Bencis Capital **

^{*Paladin Asset Management Investment stock corporation with variable capital and sub-funds}

^{** In the course of a capital increase in kind in connection with the acquisition of Ceban Pharmaceuticals B.V., 1,700,000 new shares (ISIN DE000A409682) have been issued to Bencis Buyout Fund V GP B.V., acting for the risk and for the account of Bencis Buyout Fund V C.V., Amsterdam, the Netherlands („Bencis"). These new shares are subject to a lock-up agreement entered into between Medios AG and Bencis, pursuant to which the disposal of the new shares is restricted for a period of 24 months upon completion of the transaction. Therefore, these shares will not be admitted to trading during the lock-up period.}

All figures according to voting rights notifications of the notifying parties
Share capital: €25,505,723